NEW
YORK, July 8, 2024 /PRNewswire/ -- The
global laparoscopic ablation market size is estimated to
grow by USD 1.21 billion from
2024-2028, according to Technavio. The market is estimated to grow
at a CAGR of 10.03% during the forecast
period. Increasing prevalence of chronic diseases is
driving market growth, with a trend towards emergence of
next-generation laparoscopic ablation. However, reuse and
reprocessing of devices poses a challenge. Key market players
include AngioDynamics Inc., Balmer Medical SA, Bioventus LLC,
Boston Scientific Corp., Conmed Corp., EDAP TMS, HealthTronics
Inc., Integra Lifesciences Corp., Johnson and Johnson Services
Inc., and Medtronic Plc.
Get a detailed analysis on regions, market
segments, customer landscape, and companies - Click for the
snapshot of this report
Forecast
period
|
2024-2028
|
Base Year
|
2023
|
Historic
Data
|
2018 - 2022
|
Segment
Covered
|
Application (Cancer,
Cardiovascular procedures, Urological procedures, Gynecological
procedures, and Others), Technique (Radiofrequency ablation,
Microwave ablation, Cryoablation, and Others), and Geography (North
America, Europe, Asia, and Rest of World (ROW))
|
Region
Covered
|
North America, Europe,
Asia, and Rest of World (ROW)
|
Key companies
profiled
|
AngioDynamics Inc.,
Balmer Medical SA, Bioventus LLC, Boston Scientific Corp., Conmed
Corp., EDAP TMS, HealthTronics Inc., Integra Lifesciences Corp.,
Johnson and Johnson Services Inc., and Medtronic Plc
|
Key Market Trends Fueling Growth
The global laparoscopic ablation market is experiencing growth
due to the adoption of next-generation ablation procedures, such as
robot-assisted laparoscopic ablation. This technique offers several
advantages over traditional methods, including higher accuracy in
needle insertion, improved access to complex anatomical structures,
and lower radiation dosages. Robotically controlled steerable
needles are a key feature of this approach, enabling better control
and visualization during the procedure. Advanced products like
Ablatherm Robotic HIFU and Sonatherm are driving market growth.
Ablatherm is used for prostate cancer ablation, while Sonatherm is
a robotic laparoscopic probe for soft tissue ablation. Furthermore,
integrated laparoscopic ablation instruments, such as AMICA GEN,
which combines radiofrequency and microwave ablation techniques,
are also contributing to market expansion. Overall, the
introduction of these advanced technologies is enhancing the
effectiveness and safety of laparoscopic ablation
procedures.
The laparoscopic ablation market is witnessing significant
growth due to the increasing prevalence of Hepatocellular carcinoma
(HCC) and the rising demand for minimally invasive procedures.
Companies like AngioDynamics are leading this trend with innovative
solutions like the BioFlo PICC and NanoKnife 3. Hospitals,
ambulatory surgery centers, and specialty clinics are adopting
these advanced laparoscopic ablation devices for treating various
organs, including the liver, stomach, and tissues in the abdomen.
Doctors perform these procedures using small incisions, tools, and
a camera to view the organs on a screen. Next-generation
laparoscopic ablation devices offer advantages over invasive
surgeries, such as quicker recovery time and reduced risk of
complications. The reimbursement scenario for ablation procedures
is improving, making these treatments more accessible to cancer
patients undergoing cardiovascular, urological, or gynecological
procedures. Healthcare investment in next-generation laparoscopic
ablation devices is expected to continue growing as the market
moves towards less invasive surgical diagnostic
procedures.
Discover 360° analysis of this market. For
complete information, schedule your consultation- Book
Here!
Market Challenges
- Reusable medical devices, such as laparoscopic ablation
catheters, are economically beneficial for healthcare providers as
they can be reprocessed and used on multiple patients. However,
these devices can accumulate biological debris and microorganisms,
leading to healthcare-associated infections (HAIs). To mitigate
infection risks, reprocessing involves cleaning, disassembling,
disinfecting, reassembling, inspection, function testing,
re-packing, sterilization, and relabeling. Reprocessing can occur
on-site or through third-party facilities. In regions like
Africa, Asia, Eastern
Europe, Central America,
and South America, reprocessing is
common due to cost constraints. In the US, approximately 20-30% of
hospitals reuse single-use devices, including catheters for
ablation procedures. This trend reduces the demand for new
products, thereby impacting the growth rate of the global
laparoscopic ablation market.
- The Laparoscopic Ablation Market is witnessing significant
growth due to the increasing prevalence of chronic diseases like
cancer, hypertension, unhealthy diet conditions, smoking, and
drinking. The market is driven by the adoption of minimally
invasive procedures, such as laser ablation and electrocoagulation,
using smaller incisions and advanced instruments like Helica
thermal coagulator and sub-5 mm instruments. However, challenges
include the use of laser and electric current, gas, and the risk of
abdominal wall trauma, infection, and nerve tissue damage. New
technologies like three-dimensional imaging, narrow-band imaging
(NBI), and articulated instruments are being developed to address
these challenges. Mini-laparoscopy and percutaneous instruments are
also gaining popularity for their precision and effectiveness in
treating conditions like endometriosis lesions, pelvic organ
prolapse, and prostate cancer. However, the high cost of these
advanced technologies and the need for specialized training limit
their widespread adoption. The market is also facing competition
from invasive surgical procedures like invasive surgery for kidney
stones, live donor nephrectomy, and pelvic organ prolapse, as well
as conventional medical treatments like chemotherapy and radiation
therapy, which have side effects like abdominal pain and
radiofrequency ablation, thermal ablation, cryoablation, and
fulguration. Therefore, there is a growing demand for low-cost
treatment options and the development of biological sensors and
surgical techniques to improve patient outcomes.
For more insights on driver and
challenges - Download a Sample Report
Segment Overview
This laparoscopic ablation market report extensively covers
market segmentation by
- Application
- 1.1 Cancer
- 1.2 Cardiovascular procedures
- 1.3 Urological procedures
- 1.4 Gynecological procedures
- 1.5 Others
- Technique
- 2.1 Radiofrequency ablation
- 2.2 Microwave ablation
- 2.3 Cryoablation
- 2.4 Others
- Geography
- 3.1 North America
- 3.2 Europe
- 3.3 Asia
- 3.4 Rest of World (ROW)
1.1 Cancer- Cancer is a chronic disease
characterized by the uncontrolled growth and division of cells,
leading to the formation of tumors or leukemia. Factors such as
high alcohol consumption, obesity, poor nutrition, physical
inactivity, and genetic factors contribute to its development.
Treatment for cancer varies depending on its stages and may include
chemotherapy, hormone therapy, immunotherapy, precision medicine,
radiation therapy, stem cell transplantation, targeted therapies,
and surgeries. Laparoscopic ablation, using radiofrequency and
microwave technologies, offers a minimally invasive alternative to
open surgical procedures for destroying tumor cells or tissues.
These technologies can effectively treat subcapsular lesions,
nodules adjacent to the diaphragm, and deeper tissue locations.
With the increasing global prevalence of cancer and the advantages
of laparoscopic ablation, this market is poised for growth during
the forecast period.
For more information on market segmentation with
geographical analysis including forecast (2024-2028) and historic
data (2018 - 2022) - Download a Sample Report
Research Analysis
Laparoscopic ablation is a minimally invasive surgical
diagnostic procedure used to remove or destroy abnormal tissues in
the organs located in the abdomen, such as the stomach or belly.
The process involves making small incisions and filling the abdomen
with air to create space for the surgeon to work. Laparoscopic
ablation devices include small tubes, tools, and a camera that
projects images onto a screen. Doctors use patches, laser, or
electric current to ablate the targeted tissues. The laparoscopic
ablation market is growing due to the increasing prevalence of
chronic diseases like cancer, cardiovascular, urological, and
gynecological conditions. The reimbursement scenario for these
procedures varies across hospitals and ambulatory surgery centers.
Next-generation laparoscopic ablation techniques are being
developed to improve patient outcomes and reduce recovery time.
Market Research Overview
Laparoscopic ablation is a minimally invasive surgical
diagnostic procedure used to remove or destroy abnormal tissues in
various organs, including the liver, pancreas, spleen, pelvic area,
and stomach. The procedure uses small incisions, laparoscopic
ablation devices, and tools such as cameras, screens, and patches.
Doctors utilize laser ablation, electrocoagulation, Helica thermal
coagulator, and other techniques to ablate tissues. Organs in the
abdomen, such as the liver, pancreas, and spleen, are common
targets for laparoscopic ablation. Conditions like chronic
diseases, unhealthy diet, smoking, and drinking can lead to the
need for laparoscopic ablation. The market for laparoscopic
ablation devices is growing due to the advantages of smaller
incisions, less invasive procedures, and the ability to use sub-5
mm instruments. Three-dimensional imaging, narrow-band imaging
(NBI), articulated instruments, mini-laparoscopy, and percutaneous
instruments are some of the advanced technologies used in
laparoscopic ablation. Applications of laparoscopic ablation
include the treatment of abdominal wall trauma, endometriosis
lesions, and various cancers such as hepatocellular carcinoma
(HCC). The market for laparoscopic ablation is driven by the
increasing number of cancer patients, invasive surgeries, and
healthcare investment in hospitals, ambulatory surgery centers, and
specialty clinics. However, the reimbursement scenario and
competition from conventional medical treatments like chemotherapy
and radiation therapy are key challenges. Next-generation
laparoscopic ablation techniques include radiofrequency ablation,
thermal ablation, cryoablation, and fulguration. These techniques
are used to ablate nerve tissues and treat conditions like kidney
stones, pelvic organ prolapse, and prostate cancer. The market for
laparoscopic ablation is expected to grow due to the advantages of
these next-generation techniques, which offer fewer side effects
compared to invasive surgeries. Some of the key applications of
laparoscopic ablation are in cardiovascular procedures, urological
procedures, and gynecological procedures. The market for
laparoscopic ablation is expected to grow significantly due to the
increasing prevalence of chronic diseases and the need for less
invasive and cost-effective treatments. However, the market is also
facing challenges such as the high cost of laparoscopic ablation
devices and the need for specialized training for doctors to
perform the procedure effectively. In conclusion, the laparoscopic
ablation market is expected to grow significantly due to the
increasing prevalence of chronic diseases, the need for less
invasive and cost-effective treatments, and the development of
next-generation laparoscopic ablation techniques. However, the
market is also facing challenges such as the high cost of
laparoscopic ablation devices, the need for specialized training,
and competition from conventional medical treatments. Keywords:
Laparoscopic ablation device, Surgical diagnostic procedure,
Organs, Abdomen, Tissues, Incisions, Stomach, Belly, Air, Small
tubes, Tools, Camera, Screen, Doctor, Patches, Laser, Electric
current, Gas, Laser ablation, Electrocoagulation, Helica thermal
coagulator, Smaller incision, Liver, Pancreas, Spleen, Pelvic,
Chronic diseases, Unhealthy diet conditions, Smoking, Drinking,
Hypertension, Medical science, Sub-5 mm instruments,
Three-dimensional imaging, Narrow-band imaging (NBI), Articulated
instruments, Mini-laparoscopy, Percutaneous instruments, Abdominal
wall trauma, Endometriosis lesions, Biological sensors, Surgical
techniques, Invasive surgery, Kidney stones, Live donor
nephrectomy, Pelvic organ prolapse, Prostate cancer, Low-cost
treatment, Conventional medical treatments, Cancer, Chemotherapy,
Radiation therapy, Side effects, Abdominal pain, Infection,
Radiofrequency ablation, Thermal ablation, Cryoablation,
Fulguration, Nerve tissues, Hepatocellular carcinoma (HCC),
AngioDynamics, BioFlo PICC, NanoKnife 3, Hospitals, Ambulatory
surgery centers, Specialty clinics, Cancer patients, Invasive
surgeries, Healthcare investment, Ambulatory Surgery Center,
Laparoscopic ablation market, Reimbursement scenario, Ablation
procedures, Cardiovascular procedures, Urological procedures,
Gynecological procedures, Next-generation laparoscopic
ablation.
Table of Contents:
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation
- Application
-
- Cancer
- Cardiovascular Procedures
- Urological Procedures
- Gynecological Procedures
- Others
- Technique
-
- Radiofrequency Ablation
- Microwave Ablation
- Cryoablation
- Others
- Geography
-
- North America
- Europe
- Asia
- Rest Of World (ROW)
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Company Landscape
11 Company Analysis
12 Appendix
About Technavio
Technavio is a leading global technology research and advisory
company. Their research and analysis focuses on emerging market
trends and provides actionable insights to help businesses identify
market opportunities and develop effective strategies to optimize
their market positions.
With over 500 specialized analysts, Technavio's report library
consists of more than 17,000 reports and counting, covering 800
technologies, spanning across 50 countries. Their client base
consists of enterprises of all sizes, including more than 100
Fortune 500 companies. This growing client base relies on
Technavio's comprehensive coverage, extensive research, and
actionable market insights to identify opportunities in existing
and potential markets and assess their competitive positions within
changing market scenarios.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
View original content to download
multimedia:https://www.prnewswire.com/news-releases/laparoscopic-ablation-market-size-is-set-to-grow-by-usd-1-21-billion-from-2024-2028--increasing-prevalence-of-chronic-diseases-to-boost-the-market-growth-technavio-302189664.html
SOURCE Technavio